Share Price and Basic Stock Data
Last Updated: February 11, 2026, 9:42 pm
| PEG Ratio | 1.69 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Zensar Technologies Ltd operates in the IT Consulting and Software industry, reporting a market capitalization of ₹13,960 Cr and a share price of ₹614. The company has demonstrated steady revenue growth, with sales reaching ₹4,848 Cr for the fiscal year ending March 2023, which rose to ₹4,902 Cr for the fiscal year ending March 2024. The trailing twelve months (TTM) sales stood at ₹5,491 Cr, indicating a robust upward trajectory. Quarterly sales figures further support this trend, with quarterly revenues increasing from ₹1,198 Cr in December 2022 to ₹1,241 Cr in September 2023. This growth is indicative of Zensar’s ability to capitalize on market demand, reflecting a solid position within the competitive landscape of the IT sector. Furthermore, the company’s operational efficiency is evident as it maintains a cash conversion cycle (CCC) of 55 days, aligning with industry standards which typically range between 30 to 60 days.
Profitability and Efficiency Metrics
Zensar’s profitability metrics reveal a strong operational performance, with a reported operating profit margin (OPM) of 17% for the fiscal year ending March 2023, which is expected to stabilize around 15% in subsequent periods. The net profit for the same fiscal year was ₹328 Cr, which increased to ₹650 Cr in March 2025, showcasing consistent growth. The company’s return on equity (ROE) stood at 16.4%, while the return on capital employed (ROCE) was reported at 21.3%, both indicating effective management of equity and capital investments. Additionally, the interest coverage ratio (ICR) of 56.47x highlights Zensar’s strong ability to meet interest obligations, significantly above the typical sector range of 3 to 5 times. However, the operating profit has shown fluctuations, dipping from ₹656 Cr in March 2022 to ₹552 Cr in March 2023, which may indicate potential challenges in maintaining margins amid rising operational costs.
Balance Sheet Strength and Financial Ratios
Zensar’s balance sheet reflects a stable financial position, with total assets amounting to ₹5,173 Cr as of March 2025, supported by reserves of ₹4,024 Cr. The company reported negligible borrowings of ₹125 Cr, showcasing an advantageous debt-free status that is a strength in the current economic climate. The current and quick ratios, both standing at 3.76, indicate a strong liquidity position, well above the typical benchmark of 1.5 for the IT sector, providing a buffer against short-term liabilities. Zensar’s price-to-book value (P/BV) ratio is at 3.91x, suggesting the market values the company favorably compared to its book value. However, the enterprise value (EV) to EBITDA ratio of 15.53x indicates that the stock may be trading at a premium relative to its earnings before interest, taxes, depreciation, and amortization, a factor that potential investors should consider.
Shareholding Pattern and Investor Confidence
The shareholding structure of Zensar Technologies illustrates a balanced distribution among various categories of investors. Promoters hold 49.03% of the company, a stable figure that has declined slightly from 49.15% in December 2022. Foreign institutional investors (FIIs) have reduced their stake to 13.30%, down from a peak of 16.66% in September 2023, indicating a cautious sentiment. Domestic institutional investors (DIIs), however, have increased their holdings to 22.24%, reflecting growing confidence in Zensar’s long-term prospects. The public shareholding stands at 15.43%, down from 28.63% in December 2022, which may reflect increased institutional interest at the expense of retail investors. The overall number of shareholders has declined to 201,872 as of September 2025, suggesting potential consolidation in ownership, which may impact liquidity and market dynamics.
Outlook, Risks, and Final Insight
Zensar Technologies is well-positioned for continued growth, supported by its strong revenue trajectory and solid profitability metrics. However, potential risks include fluctuating operating profits and a declining trend in foreign institutional investment, which may signal market apprehensions. The company must also navigate rising operational costs that could pressure margins. Looking ahead, Zensar could capitalize on emerging technologies and digital transformation trends, enhancing its service offerings. Nonetheless, it will need to maintain operational efficiency and manage costs effectively to sustain its competitive edge. In a scenario where global demand for IT services continues to rise, Zensar could see accelerated growth; conversely, any downturn in the technology sector may pose challenges to its growth trajectory. Overall, Zensar’s robust financial health and strategic positioning provide a solid foundation for navigating future market fluctuations.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| IDream Film Infrastructure Company Ltd | 4.50 Cr. | 300 | 332/114 | 302 | 0.00 % | % | % | 10.0 | |
| I Power Solutions India Ltd | 13.8 Cr. | 23.4 | 23.4/15.9 | 11.0 | 0.00 % | 11.6 % | 16.9 % | 10.0 | |
| Hypersoft Technologies Ltd | 125 Cr. | 76.8 | 101/19.4 | 61.2 | 9.97 | 0.00 % | 20.6 % | 9.07 % | 10.0 |
| Euphoria Infotech (India) Ltd | 10.9 Cr. | 37.4 | 64.9/32.4 | 7.34 | 58.7 | 0.00 % | 16.2 % | 11.5 % | 10.0 |
| AccelerateBS India Ltd | 51.7 Cr. | 150 | 153/67.0 | 35.2 | 15.0 | 0.67 % | 22.2 % | 17.6 % | 10.0 |
| Industry Average | 111,197.75 Cr | 782.63 | 44.54 | 156.22 | 0.81% | 20.61% | 18.63% | 7.00 |
Quarterly Result
| Metric | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,198 | 1,213 | 1,227 | 1,241 | 1,204 | 1,230 | 1,288 | 1,308 | 1,326 | 1,359 | 1,385 | 1,421 | 1,431 |
| Expenses | 1,063 | 1,037 | 997 | 1,010 | 996 | 1,027 | 1,092 | 1,107 | 1,119 | 1,146 | 1,174 | 1,201 | 1,181 |
| Operating Profit | 135 | 176 | 230 | 231 | 208 | 203 | 196 | 201 | 207 | 212 | 211 | 220 | 250 |
| OPM % | 11% | 14% | 19% | 19% | 17% | 17% | 15% | 15% | 16% | 16% | 15% | 15% | 17% |
| Other Income | 26 | 27 | 28 | 36 | 42 | 52 | 42 | 41 | 31 | 46 | 57 | 49 | 38 |
| Interest | 8 | 6 | 6 | 6 | 6 | 3 | 4 | 4 | 4 | 5 | 4 | 4 | 2 |
| Depreciation | 50 | 35 | 42 | 37 | 31 | 24 | 25 | 30 | 24 | 24 | 23 | 25 | 20 |
| Profit before tax | 104 | 162 | 210 | 225 | 212 | 229 | 210 | 208 | 210 | 230 | 241 | 240 | 265 |
| Tax % | 26% | 26% | 26% | 23% | 24% | 24% | 25% | 25% | 24% | 23% | 24% | 24% | 25% |
| Net Profit | 76 | 119 | 156 | 174 | 162 | 173 | 158 | 156 | 160 | 176 | 182 | 182 | 200 |
| EPS in Rs | 3.38 | 5.27 | 6.90 | 7.68 | 7.14 | 7.65 | 6.97 | 6.86 | 7.04 | 7.77 | 8.01 | 8.01 | 8.79 |
Last Updated: February 3, 2026, 1:16 pm
Below is a detailed analysis of the quarterly data for Zensar Technologies Ltd based on the most recent figures (Dec 2025) and their trends compared to the previous period:
- For Sales, as of Dec 2025, the value is 1,431.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,421.00 Cr. (Sep 2025) to 1,431.00 Cr., marking an increase of 10.00 Cr..
- For Expenses, as of Dec 2025, the value is 1,181.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 1,201.00 Cr. (Sep 2025) to 1,181.00 Cr., marking a decrease of 20.00 Cr..
- For Operating Profit, as of Dec 2025, the value is 250.00 Cr.. The value appears strong and on an upward trend. It has increased from 220.00 Cr. (Sep 2025) to 250.00 Cr., marking an increase of 30.00 Cr..
- For OPM %, as of Dec 2025, the value is 17.00%. The value appears strong and on an upward trend. It has increased from 15.00% (Sep 2025) to 17.00%, marking an increase of 2.00%.
- For Other Income, as of Dec 2025, the value is 38.00 Cr.. The value appears to be declining and may need further review. It has decreased from 49.00 Cr. (Sep 2025) to 38.00 Cr., marking a decrease of 11.00 Cr..
- For Interest, as of Dec 2025, the value is 2.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 4.00 Cr. (Sep 2025) to 2.00 Cr., marking a decrease of 2.00 Cr..
- For Depreciation, as of Dec 2025, the value is 20.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 25.00 Cr. (Sep 2025) to 20.00 Cr., marking a decrease of 5.00 Cr..
- For Profit before tax, as of Dec 2025, the value is 265.00 Cr.. The value appears strong and on an upward trend. It has increased from 240.00 Cr. (Sep 2025) to 265.00 Cr., marking an increase of 25.00 Cr..
- For Tax %, as of Dec 2025, the value is 25.00%. The value appears to be increasing, which may not be favorable. It has increased from 24.00% (Sep 2025) to 25.00%, marking an increase of 1.00%.
- For Net Profit, as of Dec 2025, the value is 200.00 Cr.. The value appears strong and on an upward trend. It has increased from 182.00 Cr. (Sep 2025) to 200.00 Cr., marking an increase of 18.00 Cr..
- For EPS in Rs, as of Dec 2025, the value is 8.79. The value appears strong and on an upward trend. It has increased from 8.01 (Sep 2025) to 8.79, marking an increase of 0.78.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 4:22 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 2,335 | 2,656 | 2,952 | 3,056 | 3,108 | 3,966 | 4,182 | 3,781 | 4,244 | 4,848 | 4,902 | 5,281 | 5,491 |
| Expenses | 1,977 | 2,264 | 2,513 | 2,674 | 2,743 | 3,487 | 3,689 | 3,097 | 3,587 | 4,296 | 4,030 | 4,464 | 4,641 |
| Operating Profit | 358 | 392 | 439 | 382 | 365 | 479 | 493 | 685 | 656 | 552 | 872 | 817 | 850 |
| OPM % | 15% | 15% | 15% | 12% | 12% | 12% | 12% | 18% | 15% | 11% | 18% | 15% | 15% |
| Other Income | 30 | 27 | 54 | 24 | 74 | 93 | 88 | -24 | 138 | 103 | 159 | 160 | 182 |
| Interest | 10 | 11 | 11 | 9 | 23 | 37 | 61 | 54 | 35 | 28 | 21 | 17 | 16 |
| Depreciation | 38 | 42 | 65 | 49 | 65 | 89 | 159 | 175 | 185 | 183 | 134 | 102 | 96 |
| Profit before tax | 340 | 366 | 417 | 349 | 352 | 445 | 362 | 433 | 574 | 444 | 876 | 858 | 921 |
| Tax % | 30% | 28% | 30% | 32% | 30% | 28% | 25% | 29% | 27% | 26% | 24% | 24% | |
| Net Profit | 238 | 265 | 292 | 238 | 246 | 319 | 272 | 307 | 422 | 328 | 665 | 650 | 700 |
| EPS in Rs | 10.86 | 11.94 | 12.97 | 10.47 | 10.74 | 13.93 | 11.69 | 13.30 | 18.40 | 14.47 | 29.34 | 28.61 | 30.83 |
| Dividend Payout % | 18% | 18% | 18% | 23% | 22% | 20% | 24% | 27% | 27% | 35% | 31% | 45% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 11.34% | 10.19% | -18.49% | 3.36% | 29.67% | -14.73% | 12.87% | 37.46% | -22.27% | 102.74% | -2.26% |
| Change in YoY Net Profit Growth (%) | 0.00% | -1.16% | -28.68% | 21.85% | 26.31% | -44.41% | 27.60% | 24.59% | -59.73% | 125.02% | -105.00% |
Zensar Technologies Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 7% |
| 5 Years: | 5% |
| 3 Years: | 8% |
| TTM: | 8% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 9% |
| 5 Years: | 20% |
| 3 Years: | 15% |
| TTM: | 1% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 17% |
| 5 Years: | 35% |
| 3 Years: | 50% |
| 1 Year: | -2% |
| Return on Equity | |
|---|---|
| 10 Years: | 16% |
| 5 Years: | 16% |
| 3 Years: | 16% |
| Last Year: | 16% |
Last Updated: September 5, 2025, 1:56 pm
Balance Sheet
Last Updated: December 10, 2025, 3:40 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 44 | 44 | 45 | 45 | 45 | 45 | 45 | 45 | 45 | 45 | 45 | 45 | 46 |
| Reserves | 902 | 1,113 | 1,220 | 1,427 | 1,624 | 1,897 | 2,045 | 2,297 | 2,642 | 2,931 | 3,517 | 4,024 | 4,234 |
| Borrowings | 170 | 176 | 149 | 134 | 9 | 300 | 332 | 350 | 335 | 273 | 186 | 125 | 117 |
| Other Liabilities | 370 | 402 | 455 | 500 | 618 | 847 | 1,174 | 742 | 817 | 872 | 899 | 978 | 1,016 |
| Total Liabilities | 1,486 | 1,734 | 1,869 | 2,106 | 2,296 | 3,090 | 3,596 | 3,433 | 3,840 | 4,121 | 4,648 | 5,173 | 5,412 |
| Fixed Assets | 422 | 547 | 386 | 447 | 592 | 950 | 1,323 | 1,133 | 1,254 | 1,174 | 1,034 | 1,170 | 1,184 |
| CWIP | 2 | 1 | 2 | 3 | 6 | 12 | 11 | 0 | 1 | 0 | 5 | 1 | 6 |
| Investments | 149 | 94 | 134 | 243 | 275 | 115 | 278 | 517 | 324 | 899 | 1,408 | 1,714 | 1,594 |
| Other Assets | 914 | 1,092 | 1,347 | 1,413 | 1,424 | 2,013 | 1,983 | 1,783 | 2,260 | 2,049 | 2,200 | 2,288 | 2,628 |
| Total Assets | 1,486 | 1,734 | 1,869 | 2,106 | 2,296 | 3,090 | 3,596 | 3,433 | 3,840 | 4,121 | 4,648 | 5,173 | 5,412 |
Below is a detailed analysis of the balance sheet data for Zensar Technologies Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 46.00 Cr.. The value appears strong and on an upward trend. It has increased from 45.00 Cr. (Mar 2025) to 46.00 Cr., marking an increase of 1.00 Cr..
- For Reserves, as of Sep 2025, the value is 4,234.00 Cr.. The value appears strong and on an upward trend. It has increased from 4,024.00 Cr. (Mar 2025) to 4,234.00 Cr., marking an increase of 210.00 Cr..
- For Borrowings, as of Sep 2025, the value is 117.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 125.00 Cr. (Mar 2025) to 117.00 Cr., marking a decrease of 8.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 1,016.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 978.00 Cr. (Mar 2025) to 1,016.00 Cr., marking an increase of 38.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 5,412.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 5,173.00 Cr. (Mar 2025) to 5,412.00 Cr., marking an increase of 239.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 1,184.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,170.00 Cr. (Mar 2025) to 1,184.00 Cr., marking an increase of 14.00 Cr..
- For CWIP, as of Sep 2025, the value is 6.00 Cr.. The value appears strong and on an upward trend. It has increased from 1.00 Cr. (Mar 2025) to 6.00 Cr., marking an increase of 5.00 Cr..
- For Investments, as of Sep 2025, the value is 1,594.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,714.00 Cr. (Mar 2025) to 1,594.00 Cr., marking a decrease of 120.00 Cr..
- For Other Assets, as of Sep 2025, the value is 2,628.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,288.00 Cr. (Mar 2025) to 2,628.00 Cr., marking an increase of 340.00 Cr..
- For Total Assets, as of Sep 2025, the value is 5,412.00 Cr.. The value appears strong and on an upward trend. It has increased from 5,173.00 Cr. (Mar 2025) to 5,412.00 Cr., marking an increase of 239.00 Cr..
Notably, the Reserves (4,234.00 Cr.) exceed the Borrowings (117.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 188.00 | 216.00 | 290.00 | 248.00 | 356.00 | 179.00 | 161.00 | 335.00 | 321.00 | 279.00 | 686.00 | 692.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 56 | 62 | 67 | 64 | 75 | 81 | 58 | 57 | 69 | 55 | 55 | 55 |
| Inventory Days | 272 | 266 | 304 | |||||||||
| Days Payable | 300 | 283 | 400 | |||||||||
| Cash Conversion Cycle | 28 | 45 | -29 | 64 | 75 | 81 | 58 | 57 | 69 | 55 | 55 | 55 |
| Working Capital Days | 44 | 41 | 56 | 49 | 70 | 57 | 20 | 19 | 36 | 21 | 27 | 30 |
| ROCE % | 34% | 30% | 31% | 24% | 23% | 23% | 17% | 21% | 21% | 15% | 25% | 21% |
Mutual Fund Holdings
| Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
|---|---|---|---|---|---|---|
| HDFC Small Cap Fund | 5,813,381 | 1.08 | 409.06 | 5,557,056 | 2026-01-26 00:06:15 | 4.61% |
| HDFC Hybrid Equity Fund | 5,578,744 | 1.6 | 392.55 | N/A | N/A | N/A |
| Franklin India Small Cap Fund | 3,640,478 | 1.93 | 256.16 | 3,374,581 | 2026-01-26 00:06:15 | 7.88% |
| Nippon India Small Cap Fund | 2,496,604 | 0.26 | 175.67 | 4,039,176 | 2025-05-25 10:25:42 | -38.19% |
| HSBC Value Fund | 2,406,069 | 1.15 | 169.3 | 2,508,911 | 2025-12-15 01:16:26 | -4.1% |
| Invesco India Smallcap Fund | 1,672,012 | 1.28 | 117.65 | N/A | N/A | N/A |
| Tata Digital India Fund | 1,601,303 | 0.92 | 112.68 | 1,965,123 | 2025-05-25 10:25:42 | -18.51% |
| ICICI Prudential Technology Fund | 1,539,942 | 0.68 | 108.36 | 1,462,872 | 2026-01-26 00:06:15 | 5.27% |
| HDFC Childrens Fund | 1,521,492 | 1.01 | 107.06 | N/A | N/A | N/A |
| HDFC Multi Cap Fund | 1,480,110 | 0.52 | 104.15 | 1,442,563 | 2026-01-26 00:06:15 | 2.6% |
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 |
| Basic EPS (Rs.) | 28.65 | 29.36 | 14.47 | 18.43 | 13.31 |
| Diluted EPS (Rs.) | 28.43 | 29.13 | 14.40 | 18.27 | 13.18 |
| Cash EPS (Rs.) | 33.11 | 35.27 | 22.54 | 26.84 | 21.35 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 179.28 | 157.26 | 131.40 | 118.89 | 105.10 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 179.28 | 157.26 | 131.40 | 118.89 | 105.10 |
| Revenue From Operations / Share (Rs.) | 232.63 | 216.42 | 214.05 | 187.78 | 167.61 |
| PBDIT / Share (Rs.) | 43.04 | 45.50 | 28.92 | 35.14 | 31.48 |
| PBIT / Share (Rs.) | 38.55 | 39.59 | 20.84 | 26.96 | 23.74 |
| PBT / Share (Rs.) | 37.78 | 38.67 | 19.61 | 25.40 | 19.19 |
| Net Profit / Share (Rs.) | 28.63 | 29.36 | 14.46 | 18.66 | 13.61 |
| NP After MI And SOA / Share (Rs.) | 28.63 | 29.36 | 14.46 | 18.42 | 13.30 |
| PBDIT Margin (%) | 18.49 | 21.02 | 13.51 | 18.71 | 18.78 |
| PBIT Margin (%) | 16.57 | 18.29 | 9.73 | 14.35 | 14.16 |
| PBT Margin (%) | 16.24 | 17.86 | 9.16 | 13.52 | 11.44 |
| Net Profit Margin (%) | 12.30 | 13.56 | 6.75 | 9.93 | 8.11 |
| NP After MI And SOA Margin (%) | 12.30 | 13.56 | 6.75 | 9.80 | 7.93 |
| Return on Networth / Equity (%) | 15.96 | 18.66 | 11.00 | 15.49 | 12.80 |
| Return on Capital Employeed (%) | 20.39 | 23.63 | 14.46 | 20.03 | 19.87 |
| Return On Assets (%) | 12.56 | 14.30 | 7.94 | 10.75 | 8.73 |
| Long Term Debt / Equity (X) | 0.00 | 0.00 | 0.00 | 0.08 | 0.00 |
| Total Debt / Equity (X) | 0.00 | 0.00 | 0.00 | 0.08 | 0.00 |
| Asset Turnover Ratio (%) | 1.08 | 1.12 | 1.21 | 0.54 | 0.46 |
| Current Ratio (X) | 3.76 | 3.04 | 2.70 | 2.73 | 2.70 |
| Quick Ratio (X) | 3.76 | 3.04 | 2.70 | 2.73 | 2.70 |
| Dividend Payout Ratio (NP) (%) | 31.40 | 18.73 | 34.55 | 21.16 | 9.01 |
| Dividend Payout Ratio (CP) (%) | 27.15 | 15.59 | 22.16 | 14.65 | 5.69 |
| Earning Retention Ratio (%) | 68.60 | 81.27 | 65.45 | 78.84 | 90.99 |
| Cash Earning Retention Ratio (%) | 72.85 | 84.41 | 77.84 | 85.35 | 94.31 |
| Interest Coverage Ratio (X) | 56.47 | 49.31 | 23.48 | 22.50 | 13.27 |
| Interest Coverage Ratio (Post Tax) (X) | 38.56 | 32.82 | 12.74 | 12.95 | 7.65 |
| Enterprise Value (Cr.) | 15171.37 | 12988.21 | 5476.97 | 7684.40 | 5517.20 |
| EV / Net Operating Revenue (X) | 2.87 | 2.65 | 1.13 | 1.81 | 1.46 |
| EV / EBITDA (X) | 15.53 | 12.60 | 8.36 | 9.68 | 7.77 |
| MarketCap / Net Operating Revenue (X) | 3.01 | 2.80 | 1.28 | 1.96 | 1.64 |
| Retention Ratios (%) | 68.59 | 81.26 | 65.44 | 78.83 | 90.98 |
| Price / BV (X) | 3.91 | 3.85 | 2.08 | 3.09 | 2.64 |
| Price / Net Operating Revenue (X) | 3.01 | 2.80 | 1.28 | 1.96 | 1.64 |
| EarningsYield | 0.04 | 0.04 | 0.05 | 0.05 | 0.04 |
After reviewing the key financial ratios for Zensar Technologies Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 2.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 2.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 28.65. This value is within the healthy range. It has decreased from 29.36 (Mar 24) to 28.65, marking a decrease of 0.71.
- For Diluted EPS (Rs.), as of Mar 25, the value is 28.43. This value is within the healthy range. It has decreased from 29.13 (Mar 24) to 28.43, marking a decrease of 0.70.
- For Cash EPS (Rs.), as of Mar 25, the value is 33.11. This value is within the healthy range. It has decreased from 35.27 (Mar 24) to 33.11, marking a decrease of 2.16.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 179.28. It has increased from 157.26 (Mar 24) to 179.28, marking an increase of 22.02.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 179.28. It has increased from 157.26 (Mar 24) to 179.28, marking an increase of 22.02.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 232.63. It has increased from 216.42 (Mar 24) to 232.63, marking an increase of 16.21.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 43.04. This value is within the healthy range. It has decreased from 45.50 (Mar 24) to 43.04, marking a decrease of 2.46.
- For PBIT / Share (Rs.), as of Mar 25, the value is 38.55. This value is within the healthy range. It has decreased from 39.59 (Mar 24) to 38.55, marking a decrease of 1.04.
- For PBT / Share (Rs.), as of Mar 25, the value is 37.78. This value is within the healthy range. It has decreased from 38.67 (Mar 24) to 37.78, marking a decrease of 0.89.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 28.63. This value is within the healthy range. It has decreased from 29.36 (Mar 24) to 28.63, marking a decrease of 0.73.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 28.63. This value is within the healthy range. It has decreased from 29.36 (Mar 24) to 28.63, marking a decrease of 0.73.
- For PBDIT Margin (%), as of Mar 25, the value is 18.49. This value is within the healthy range. It has decreased from 21.02 (Mar 24) to 18.49, marking a decrease of 2.53.
- For PBIT Margin (%), as of Mar 25, the value is 16.57. This value is within the healthy range. It has decreased from 18.29 (Mar 24) to 16.57, marking a decrease of 1.72.
- For PBT Margin (%), as of Mar 25, the value is 16.24. This value is within the healthy range. It has decreased from 17.86 (Mar 24) to 16.24, marking a decrease of 1.62.
- For Net Profit Margin (%), as of Mar 25, the value is 12.30. This value exceeds the healthy maximum of 10. It has decreased from 13.56 (Mar 24) to 12.30, marking a decrease of 1.26.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 12.30. This value is within the healthy range. It has decreased from 13.56 (Mar 24) to 12.30, marking a decrease of 1.26.
- For Return on Networth / Equity (%), as of Mar 25, the value is 15.96. This value is within the healthy range. It has decreased from 18.66 (Mar 24) to 15.96, marking a decrease of 2.70.
- For Return on Capital Employeed (%), as of Mar 25, the value is 20.39. This value is within the healthy range. It has decreased from 23.63 (Mar 24) to 20.39, marking a decrease of 3.24.
- For Return On Assets (%), as of Mar 25, the value is 12.56. This value is within the healthy range. It has decreased from 14.30 (Mar 24) to 12.56, marking a decrease of 1.74.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 0.2. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 1.08. It has decreased from 1.12 (Mar 24) to 1.08, marking a decrease of 0.04.
- For Current Ratio (X), as of Mar 25, the value is 3.76. This value exceeds the healthy maximum of 3. It has increased from 3.04 (Mar 24) to 3.76, marking an increase of 0.72.
- For Quick Ratio (X), as of Mar 25, the value is 3.76. This value exceeds the healthy maximum of 2. It has increased from 3.04 (Mar 24) to 3.76, marking an increase of 0.72.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 31.40. This value is within the healthy range. It has increased from 18.73 (Mar 24) to 31.40, marking an increase of 12.67.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 27.15. This value is within the healthy range. It has increased from 15.59 (Mar 24) to 27.15, marking an increase of 11.56.
- For Earning Retention Ratio (%), as of Mar 25, the value is 68.60. This value is within the healthy range. It has decreased from 81.27 (Mar 24) to 68.60, marking a decrease of 12.67.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 72.85. This value exceeds the healthy maximum of 70. It has decreased from 84.41 (Mar 24) to 72.85, marking a decrease of 11.56.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 56.47. This value is within the healthy range. It has increased from 49.31 (Mar 24) to 56.47, marking an increase of 7.16.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 38.56. This value is within the healthy range. It has increased from 32.82 (Mar 24) to 38.56, marking an increase of 5.74.
- For Enterprise Value (Cr.), as of Mar 25, the value is 15,171.37. It has increased from 12,988.21 (Mar 24) to 15,171.37, marking an increase of 2,183.16.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 2.87. This value is within the healthy range. It has increased from 2.65 (Mar 24) to 2.87, marking an increase of 0.22.
- For EV / EBITDA (X), as of Mar 25, the value is 15.53. This value exceeds the healthy maximum of 15. It has increased from 12.60 (Mar 24) to 15.53, marking an increase of 2.93.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 3.01. This value exceeds the healthy maximum of 3. It has increased from 2.80 (Mar 24) to 3.01, marking an increase of 0.21.
- For Retention Ratios (%), as of Mar 25, the value is 68.59. This value is within the healthy range. It has decreased from 81.26 (Mar 24) to 68.59, marking a decrease of 12.67.
- For Price / BV (X), as of Mar 25, the value is 3.91. This value exceeds the healthy maximum of 3. It has increased from 3.85 (Mar 24) to 3.91, marking an increase of 0.06.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 3.01. This value exceeds the healthy maximum of 3. It has increased from 2.80 (Mar 24) to 3.01, marking an increase of 0.21.
- For EarningsYield, as of Mar 25, the value is 0.04. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 24) which recorded 0.04.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Zensar Technologies Ltd:
- Net Profit Margin: 12.3%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 20.39% (Industry Average ROCE: 20.61%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 15.96% (Industry Average ROE: 18.63%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 38.56
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 3.76
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 18.4 (Industry average Stock P/E: 44.54)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 12.3%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| IT Consulting & Software | Zensar Knowledge Park, Plot # 4, MIDC Kharadi, Pune Maharashtra 411014 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. H V Goenka | Chairman & Non-Exe.Director |
| Mr. Anant Vardhan Goenka | Vice Chairman & Non Exe.Dire |
| Mr. Manish Tandon | Managing Director & CEO |
| Mr. Ketan Dalal | Ind. Non-Executive Director |
| Mr. Ben Druskin | Ind. Non-Executive Director |
| Ms. Radha Rajappa | Ind. Non-Executive Director |
| Mr. U B Pravin Rao | Ind. Non-Executive Director |
| Mr. Harsh Mariwala | Ind. Non-Executive Director |
FAQ
What is the intrinsic value of Zensar Technologies Ltd?
Zensar Technologies Ltd's intrinsic value (as of 12 February 2026) is ₹513.87 which is 16.31% lower the current market price of ₹614.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's ₹13,960 Cr. market cap, FY2025-2026 high/low of ₹902/536, reserves of ₹4,234 Cr, and liabilities of ₹5,412 Cr.
What is the Market Cap of Zensar Technologies Ltd?
The Market Cap of Zensar Technologies Ltd is 13,960 Cr..
What is the current Stock Price of Zensar Technologies Ltd as on 12 February 2026?
The current stock price of Zensar Technologies Ltd as on 12 February 2026 is ₹614.
What is the High / Low of Zensar Technologies Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Zensar Technologies Ltd stocks is ₹902/536.
What is the Stock P/E of Zensar Technologies Ltd?
The Stock P/E of Zensar Technologies Ltd is 18.4.
What is the Book Value of Zensar Technologies Ltd?
The Book Value of Zensar Technologies Ltd is 188.
What is the Dividend Yield of Zensar Technologies Ltd?
The Dividend Yield of Zensar Technologies Ltd is 2.12 %.
What is the ROCE of Zensar Technologies Ltd?
The ROCE of Zensar Technologies Ltd is 21.3 %.
What is the ROE of Zensar Technologies Ltd?
The ROE of Zensar Technologies Ltd is 16.4 %.
What is the Face Value of Zensar Technologies Ltd?
The Face Value of Zensar Technologies Ltd is 2.00.